Projects per year
Personal profile
Education
- 1981 Ph.D., Biochemistry, Lille Science and Technology University, France
- 1977 Master of Science, Biochemistry, Lille Science and Technology University, France
- 1976 Bachelor of Science, Lille Science and Technology University, France
Experience
- Distinguished Professor, College of Biomedical Engineering, Taipei Medical University
- 2020.01- Professor, Ph.D. Program in Neuroscience of Cognition and Consciousness, Taipei Medical University
- 2018.02- Professor, International Ph.D Program for Cell Therapy and Regeneration Medicine, Taipei Medical University
- 2017.10- Vice Dean, College of Biomedical Engineering, Taipei Medical University
- 2016.08-2022.07 Director, International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University
- 2015.08- Professor, Graduate Institute of Biomaterials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University
- 2014- Treasurer, Working Party on Cellular Therapies, International Society of Blood Transfusion
- 2012- Organising Committee member of the Working Party of Global Blood Safety, International Society of Transfusion Medicine
- 2013.08-2015 Director, Graduate Institute of Biomaterials and Tissue Engineering, College of Oral Medicine, Taipei Medical University
- 2012.08-2015 Professor, Graduate Institute of Biomaterials and Tissue Engineering, College of Oral Medicine, Taipei Medical University
- 2008.08- Taipei Medical University, Taipei, Taiwan
- 2008.08-2012.08 Visiting Professor, Graduate Institute of Medical Sciences, College of Oral Medicine ; “Foreign Expert” laureate from the National Science Council (NSC) of Taiwan
- 1998.01-2012 Human Protein Process Sciences, Lille, France
- Director
- Expert and International Consultant for Process and Biological product development (human blood & plasma products, recombinant products, animal-derived antisera); supervises research and development work on biological products
- World Health Organization Expert
- 1995.09-1997.12 Haemonetics Corporation, Boston, Ma., USA
- Vice President, Haemonetics Corporation, Boston, USA
- Director, Haemonetics Plasma product Services (HPPS), Nyon, Switzerland
- Member of the International Management Committee
- 1994.06-1995.09 Laboratoire Français du Fractionnement et des Biotechnologies (French National Plasma Fractionation and Biotechnology Laboratory), Paris, France
- 1995.01-1995.09 National Scientific Director (120 researchers and assistants)
- 1995.01 General Manager, Lille plasma fractionation plant (280 employees)
- Member of the Executive Committee, International Committee, and Scientific Committee
- 1986.09-1994.06 Regional Blood Transfusion Center - Lille - CRTS-Lille, France
- 1990 Director, plasma fractionation centre (150 employees)
- 1986 Chief of Department, plasma fractionation service (350 employees)
- Member of the Executive Committee
- 1984.10-1986.09 Regional Blood Transfusion Center - Lille - CRTS-Lille, France
- Chief of Research and Development laboratory
- 1982.05-1984.10 Northern Regional Research Center, USDA, Peoria, Illinois, USA
- Post-doctoral Research Assistant (University of Nebraska, Lincoln, USA), based at the Northern Regional Research Centre, IL., USA
Awards
- MOST Outstanding Research Award in 2021
- TMU excellent research award in 109 academic year
- 2019 Award from the International Plasma Fractionation Association
-
Outstanding research papers award in 106 academic year
- Award for Recruitment and Retention of Special and Outstanding Talents by MOST in 106 academic year
- Outstanding research papers award in 105 academic year
- Excellent Teacher Award in 105 academic year
Research Interests
- Platelet growth factors for regenerative medicine and cell therapy
- Plasma fractionation
- Viral inactivation technologies
- Blood biotechnology
Related Link
Fingerprint
- 1 Similar Profiles
Network
-
Growth Factors-Rich Evs-Functionalized Graphene-On-Hydrogel Based Skin Bioactive Regeneration Scaffolds( II )
1/1/23 → 12/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
Bio-Engineered Platelet Secretome Biomaterials for Brain Rejuvenation( II )
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
Intranassal immunotherapy of neurological disorders-prospective translation assessment
7/1/22 → 2/28/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
Growth Factors-Rich Evs-Functionalized Graphene-On-Hydrogel Based Skin Bioactive Regeneration Scaffolds( I )
1/1/22 → 12/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
Platelet Microvesicles as Targeted Anti-cancer Drug Delivery Tools
1/1/22 → 12/31/22
Project: A - Government Institution › a - National Health Research Institutes
-
Abstract 6723: Application of in vitro drug screening of circulating tumor cells in pediatric glioma therapy
Liu, Y-L., Chen, Y-J., Chen, S-H., Liao, Y-M., Shih-Pei, W., Chen, Y-H., Ho, W-L., Juo, L-Y., Chang, C-Y., Wang, J-L., Su, M-Y., Lin, P-C., Wang, S-C., Miser, J. S., Wong, T-T., Wu, Y-H., Wang, P. Y., Burnouf, T., Chiou, J-F. & Lu, L-S., 2023, In: Cancer Research. 83, 7_Supplement, p. 6723 1 p.Research output: Contribution to journal › Article › peer-review
-
Eye drops of human origin—Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies
Gabriel, C., Marks, D. C., Henschler, R., Schallmoser, K., Burnouf, T. & Koh, M. B. C., 2023, (Accepted/In press) In: Vox Sanguinis. 118, 4, p. 301-309 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Hematological toxicities of immune checkpoint inhibitors and the impact of blood transfusion and its microbiome on therapeutic efficacy and recipient's safety and survival outcome:A systematic narrative appraisal of where we are now!
Shouman, M., Goubran, H., Seghatchian, J. & Burnouf, T., 2023, (Accepted/In press) In: Transfusion and Apheresis Science. 103685.Research output: Contribution to journal › Review article › peer-review
-
Neuroprotective activity of a virus-safe nanofiltered human platelet lysate depleted of extracellular vesicles in Parkinson's disease and traumatic brain injury models
Delila, L., Nebie, O., Le, N. T. N., Barro, L., Chou, M. L., Wu, Y. W., Watanabe, N., Takahara, M., Buée, L., Blum, D., Devos, D. & Burnouf, T., Jan 2023, In: Bioengineering and Translational Medicine.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Treatment Response Prediction with Circulating Tumor Cell-Derived Organoids for Soft Tissue Sarcoma
Liu, Y. W., Burnouf, T. P. R., Chang, C-Y., Chen, S-H., Chen, Y-J., Chen, Y. H., Ho, W. L., Liao, Y-M., Lin, P. C., Liu, Y. L., Miser, J. S., Wang, J. L., Wang, P. Y., Wang, S. C., Wong, T-T., Wu, S-P., Wu, Y. H., Chiou, J-F. & Lu, L-S., Jun 2023, (Accepted/In press).Research output: Contribution to conference › Poster › peer-review
Datasets
-
MOESM2 of The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates
Devos, D. (Creator), Blum, D. (Creator), Burnouf, T. P. R. (Creator), Devedjian, J. (Contributor), Bordet, R. (Creator), Nebie, O. (Contributor), Chou, M. (Creator), Jonneaux, A. (Creator), Barro, L. (Contributor), Vingtdeux, V. (Creator), Bu?e, L. (Contributor) & Knutson, F. (Creator), Figshare, 2019
DOI: 10.6084/m9.figshare.10094564.v1, https://doi.org/10.6084%2Fm9.figshare.10094564.v1
Dataset
-
Extensive characterization of the composition and functional activities of five preparations of human platelet lysates for dedicated clinical uses
Delila, L. (Contributor), Wu, Y. (Creator), Nebie, O. (Contributor), Widyaningrum, R. (Contributor), Chou, M. (Creator), Devos, D. (Creator) & Burnouf, T. P. R. (Creator), Taylor & Francis, 2020
DOI: 10.6084/m9.figshare.13350522, https://tandf.figshare.com/articles/dataset/Extensive_characterization_of_the_composition_and_functional_activities_of_five_preparations_of_human_platelet_lysates_for_dedicated_clinical_uses/13350522
Dataset
-
Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop
Wu, Y. (Creator), Huang, C. (Contributor), Changou, C. A. (Creator), Lu, L. (Creator), Goubran, H. (Creator) & Burnouf, T. P. R. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.4903896.v1, https://springernature.figshare.com/collections/Clinical-grade_cryopreserved_doxorubicin-loaded_platelets_role_of_cancer_cells_and_platelet_extracellular_vesicles_activation_loop/4903896/1
Dataset
-
Additional file 4 of Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop
Wu, Y. (Creator), Huang, C. (Contributor), Changou, C. A. (Creator), Lu, L. (Creator), Goubran, H. (Creator) & Burnouf, T. P. R. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12017388.v1, https://springernature.figshare.com/articles/Additional_file_4_of_Clinical-grade_cryopreserved_doxorubicin-loaded_platelets_role_of_cancer_cells_and_platelet_extracellular_vesicles_activation_loop/12017388/1
Dataset
-
Additional file 1 of Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop
Wu, Y. (Creator), Huang, C. (Contributor), Changou, C. A. (Creator), Lu, L. (Creator), Goubran, H. (Creator) & Burnouf, T. P. R. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12017379.v1, https://springernature.figshare.com/articles/Additional_file_1_of_Clinical-grade_cryopreserved_doxorubicin-loaded_platelets_role_of_cancer_cells_and_platelet_extracellular_vesicles_activation_loop/12017379/1
Dataset